After promising data, experts say many questions remain over an experimental Alzheimer’s drug
By Brenda Goodman, CNN The experimental Alzheimer’s drug lecanemab made big news last week when the companies testing it released trial results that showed the drug met its goals, making it one of the first dementia drugs to return positive results. In a randomized, placebo-controlled study of nearly 1,800 people who were in the early
Continue Reading